Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 124.96M P/E - EPS this Y 35.50% Ern Qtrly Grth -
Income -135.12M Forward P/E -1.25 EPS next Y 13.70% 50D Avg Chg -9.00%
Sales 832.01k PEG -0.08 EPS past 5Y - 200D Avg Chg -61.00%
Dividend N/A Price/Book 0.63 EPS next 5Y 41.50% 52W High Chg -83.00%
Recommedations 2.40 Quick Ratio 3.47 Shares Outstanding 23.37M 52W Low Chg 25.00%
Insider Own 1.61% ROA -32.11% Shares Float 22.99M Beta 1.05
Inst Own 18.50% ROE -79.55% Shares Shorted/Prior 1.86M/1.43M Price 0.48
Gross Margin - Profit Margin - Avg. Volume 9,115,987 Target Price 19.25
Oper. Margin -26,686.29% Earnings Date May 8 Volume 2,949,979 Change -4.38%
About Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Inovio Pharmaceuticals, Inc. News
03/26/24 INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
03/08/24 Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
03/07/24 Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
03/07/24 Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
03/06/24 Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
03/06/24 INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
03/06/24 Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
02/21/24 Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know
02/21/24 INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
02/12/24 Inovio (INO) Moves 17.4% Higher: Will This Strength Last?
02/07/24 INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
02/02/24 INOVIO Reports Inducement Grant Under Inducement Plan
01/30/24 How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%
01/23/24 INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
01/22/24 INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
01/12/24 Inovio Pharma (INO) Stock Rallies 134% in a Month: Here's Why
01/04/24 INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
01/03/24 INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
11/14/23 The 3 Most Undervalued Biotech Stocks to Buy: November 2023
11/10/23 Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
INO Chatroom

User Image gaizka36 Posted - 36 minutes ago

$INO please, pretty please push it below 11 with these 100 shares PM and i buy more instantly, this money will generate profit before the session starts😀

User Image SalTheStockBroker143 Posted - 6 hours ago

$INO Keep in mind this had a reverse split. $300-500 per share is definitely a possibility in the next three years in my opinion. i just keep loading up while the price is still low.

User Image SalTheStockBroker143 Posted - 6 hours ago

$INO Nice to see i ran that goof with photoshopped picture of jackie shea. Imagine spending time doing that? lol what a loser

User Image AHeavyPig Posted - 7 hours ago

$INO when I get my lawsuit money I’ll put it right back into this stock 🤣 calculated $ after lawyer fees etc is around $50k.

User Image Buqqets Posted - 7 hours ago

$INO now if only Kies can keep his disgusting slimy fingers off the ATM button for 3 more days.......

User Image INOxray8 Posted - 8 hours ago

$INO Crickets Yeah, it’s the deafening sound of troll silence. What happened?!??!! You were all so chatty last year. Those of you that were so eager to trash this stock and its management. And anyone on these boards that dared call out your FUD and blatant lies. Where’d you all go? Cat got your tongue? Or does Inovio now literally own you? Because you finally have to buy the REAL stock back. And unfortunately for you, those shares do not exist. Just like the fake shares you dumped on the market the last two years. Just absolute vapor. Can’t cover? Too bad. Too sad. Because you’re being vaporized at this very moment. It really feels good to have been right the whole time. imho xx

User Image Tarheel_Trader Posted - 8 hours ago

$INO. 2 large news stories due out anytime between tomorrow and June 30th .. Thats only a 66 business day window. 3107 trial news, and 3112 news could happen as well.

User Image betaino Posted - 10 hours ago

$INO https://www.science.org/content/article/bird-flu-discovered-u-s-dairy-cows-disturbing

User Image Lookingdown Posted - 10 hours ago

$INO Inovio is referenced in this article New vaccine technologies in veterinary medicine: a herald of vaccines for human medicine March 27, 2024 https://axoncomunicacion.net/nuevas-tecnologias-de-vacunas-en-medicina-veterinaria-un-heraldo-de-las-vacunas-para-la-medicina-humana/

User Image Benji__ Posted - 11 hours ago

$INO Next avtx...

User Image CCkellboy Posted - 11 hours ago

$INO nice green candle off yesterday’s inverted hammer. The trend continues upward.

User Image CptHubes Posted - 11 hours ago

$INO Past: R/S every 10 years Future: Stock split every 10 years 💡 ⚡️

User Image lotus456 Posted - 11 hours ago

$INO 💪💪💯

User Image GrumpySasquatch Posted - 12 hours ago

$INO

User Image subeih Posted - 12 hours ago

$INO so i bought ino back in 2020 at 17.60 USD. Considering the reverse split and the losses throught the past years in order for me to break even i need this stockto reach 205 usd is this at all possible?

User Image Blade_runr Posted - 12 hours ago

$INO ... Traditional P&F daily price action standard box. Let's hope this triple top breakout drops like triple top did in past. Need 14 to print before this tanks.

User Image Tracker7 Posted - 12 hours ago

$INO

User Image jabramowitz Posted - 12 hours ago

$INO go go go

User Image patcarr Posted - 12 hours ago

$INO 8,654 shares/$13.03 at the close, on very low volume of 291,430 shares and 40% dark pool activity. Shorts don't seem to have an appetite here; and I believe that they are already trying to close out their positions, whilst keeping a lid on the PPS. Jackie Shea, I believe is a keynote speaker at the JPM conference April 2 at 10 AM ET. THIS MAY BE THE LAUNCH PAD. GLT Longs. Those that have been trying to destroy Little INO have been painted into a corner IMHO.

User Image Lookingdown Posted - 13 hours ago

$INO Did I mention I love Green😎😉

User Image ScatP392 Posted - 13 hours ago

$INO Finished over 13! Maybe there is hope I won't have to jump! Lfg!

User Image RajCx Posted - 13 hours ago

$INO This is so manipulated with options. So many days it ends around whole numbers, bouncing back and forth. So obvious!

User Image beefree Posted - 13 hours ago

$INO boom right at resistance

User Image cismocole Posted - 13 hours ago

$INO good

User Image Dany_italy Posted - 13 hours ago

$INO yessss

User Image beefree Posted - 13 hours ago

$INO no selloff today like i said cmon hold over 13

User Image RajCx Posted - 13 hours ago

$INO Not celebrating, but this is how I feel about this stock right now...

User Image beefree Posted - 13 hours ago

$INO dow up 500 points thought we be well into 13.50 ish

User Image beefree Posted - 13 hours ago

$INO 3times we hit that 13.05 thats the new resistance

Analyst Ratings
Oppenheimer Outperform Mar 8, 24
RBC Capital Sector Perform Mar 7, 24
Oppenheimer Outperform Jan 25, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Weiner David B. Director Director Mar 11 Sell 1.15 5,833 6,708 910,124 03/13/23
Weiner David B. Director Director Feb 26 Sell 1.28 11,668 14,935 904,291 02/28/23
Weiner David B. Director Director Aug 11 Option 2.16 11,875 25,650 904,500 08/11/22
Weiner David B. Director Director Aug 11 Sell 2.66 11,875 31,588 892,625 08/11/22
BENITO SIMON X Director Director Mar 16 Option 2.2 2,000 4,400 59,305 03/17/22
BENITO SIMON X Director Director Mar 16 Sell 3.16 2,000 6,320 57,305 03/17/22
Weiner David B. Director Director Mar 08 Sell 3.33 4,083 13,596 876,041 03/09/22
Weiner David B. Director Director Apr 21 Option 2.4 22,500 54,000 877,719 04/21/21
BENITO SIMON X Director Director Apr 16 Option 3.56 2,000 7,120 53,650 04/16/21
Weiner David B. Director Director Mar 09 Sell 9.39 7,000 65,730 843,552 03/09/21
Kim Jong Joseph Chief Executive Offi.. Chief Executive Officer Feb 03 Option 4.56 62,500 285,000 1,140,813 02/03/21
Kim Jong Joseph Chief Executive Offi.. Chief Executive Officer Feb 03 Sell 14.62 162,500 2,375,750 1,078,313 02/03/21
Shea Jacqueline Elizabeth Chief Operating Offi.. Chief Operating Officer Feb 03 Option 3.62 22,376 81,001 66,871 02/03/21
Shea Jacqueline Elizabeth Chief Operating Offi.. Chief Operating Officer Feb 03 Sell 15.03 28,336 425,890 38,535 02/03/21
KIES PETER CFO CFO Jan 15 Option 4.56 30,000 136,800 149,290 01/15/21
KIES PETER CFO CFO Jan 15 Sell 10.02 30,000 300,600 119,290 01/15/21
KIES PETER CFO CFO Dec 17 Option 2.28 20,000 45,600 139,290 12/17/20
KIES PETER CFO CFO Dec 17 Sell 10.69 20,000 213,800 119,290 12/17/20
Weiner David B. Director Director Dec 17 Option 4.56 17,500 79,800 844,719 12/17/20
Weiner David B. Director Director Dec 17 Sell 10.71 17,500 187,425 827,219 12/17/20